Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03868670 · ClinicalTrials.gov registry record · NA
Responsive Neurostimulation For Loss Of Control Eating
A NA study of Obesity, Morbid and Loss-of-control Eating, sponsored by University of Pennsylvania.
- Active
- Registry status
- NA
- Development phase
- 6
- Enrollment target
- 2
- Study locations
NCT03868670: Active NA study of Obesity, Morbid and Loss-of-control Eating, sponsored by University of Pennsylvania.
NCT03868670 is a NA study of Obesity, Morbid and Loss-of-control Eating that is active but no longer recruiting, run by University of Pennsylvania. The registered enrollment target is 6 participants, below the 103-participant average among 19 other Obesity, Morbid trials with a reported enrollment target (94% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03868670, a NA study of Obesity, Morbid and Loss-of-control Eating, is active but no longer recruiting, sponsored by University of Pennsylvania.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
- 2
- Study locations
Study Summary
The primary objective of this trial is to assess device function and safety, with secondary objectives including the feasibility.
Primary Outcome
Safety of the RNS System and NAc stimulation through evaluation of AE's graded as "related" (vs. not related) to the intervention that will be graded based on severity. Grade 1 Mild AE Grade 2 Moderate AE Grade 3 Severe AE Grade 4 Life-threatening or disabling AE Grade 5 Death related to AE
Conditions Studied
Interventions
- DEVICE responsive neurostimulation
Study Locations (2)
California
- Stanford University - Stanford
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2019-04-10 |
| Est. Completion | 2028-01-01 |
| Phase | NA |
What the registry record for NCT03868670 still lists
NCT03868670 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 103-participant average among 19 other Obesity, Morbid trials with a reported enrollment target (94% lower).
The record links to 2 conditions, with Obesity, Morbid appearing as the primary indexed condition, and to 1 intervention - of which responsive neurostimulation is the first listed.
NCT03868670 reports a single indexed study location in California, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03868670 about?
NCT03868670 is a clinical study titled "Responsive Neurostimulation For Loss Of Control Eating". The primary objective of this trial is to assess device function and safety, with secondary objectives including the feasibility.
What is the current status of trial NCT03868670?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 6 participants. The study started on 2019-04-10. Estimated completion is 2028-01-01.
What conditions does trial NCT03868670 study?
This clinical trial studies the following conditions: Obesity, Morbid, Loss-of-control Eating.
What interventions are being tested in trial NCT03868670?
The interventions under investigation include: responsive neurostimulation (DEVICE).
Who is sponsoring clinical trial NCT03868670?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03868670 being conducted?
This trial has 2 study locations across California, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity, Morbid
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03868670's enrollment target sits among peer trials
6 19th of 19 the lowest of 19 other Obesity, Morbid trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity, Morbid trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Trans-nasal Endoscopy for Bariatric Patients
RECRUITING · NA
-
Time-restricted Eating Among Pregnant Females With Severe Obesity
RECRUITING · NA
-
Long-term, Substantial Weight Loss and Insulin Regulation of Lipolysis
RECRUITING · NA
-
Brown Adipose Tissue Activation by Spinal Cord Stimulation
RECRUITING · NA
-
Postextubation Use of Noninvasive Respiratory Support in Severely Obese Patients
RECRUITING · NA
-
Evaluation of Bariatric Endoscopic Antral Myotomy (BEAM) as a Treatment for Obesity
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI